Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| PLYX | Polaryx Therapeutics | $6.37 | $2.85 | 80.97% | 19.1M | $167M | $2.20$48.91 |
| ATPC | Agape Atp | $3.23 | $1.21 | 59.80% | 58.1M | $2.0M | $1.72$128.25 |
| ACXP | Acurx Pharmaceuticals | $2.88 | $0.93 | 47.31% | 28.4M | $5.0M | $1.33$21.00 |
| MGNX | MacroGenics | $3.45 | $1.09 | 46.19% | 357.6K | $149M | $0.99$3.50 |
| PIII | P3 Health Partners | $4.01 | $1.13 | 38.99% | 651.8K | $9.5M | $1.52$11.30 |
| INKT | MiNK Therapeutics | $13.67 | $3.22 | 30.81% | 242K | $49M | $6.34$76.00 |
| CRMU | Themes ETF Trust - Leverage Shares 2x Long Crml Daily ETF | $9.77 | $2.17 | 28.52% | 63.2K | - | $6.52$15.25 |
| BUUU | Buuu Group | $16.87 | $3.61 | 27.22% | 23.2K | $221M | $3.67$20.76 |
| OCC | Optical Cable | $7.73 | $1.62 | 26.51% | 645.7K | $54M | $2.40$11.50 |
| AGCC | Agencia Comercial Spirits | $22.88 | $4.68 | 25.71% | 25.8K | $626M | $3.66$24.98 |
| LFMD | LifeMD | $3.91 | $0.79 | 25.32% | 136.8K | $150M | $2.56$15.84 |
| TKNO | Alpha Teknova | $2.58 | $0.46 | 21.70% | 10.8K | $114M | $1.91$7.48 |
| AIFF | Firefly Neuroscience | $2.03 | $0.36 | 21.56% | 3.4M | $24M | $0.62$6.00 |
| ZVRA | Zevra Therapeutics | $11.06 | $1.94 | 21.27% | 269.4K | $513M | $6.19$13.16 |
| ZNTL | Zentalis Pharmaceuticals | $3.00 | $0.52 | 20.97% | 117K | $179M | $1.01$3.95 |
| TTEC | TTEC Holdings | $3.01 | $0.52 | 20.88% | 76.1K | $121M | $1.98$5.60 |
| BIRD | Allbirds | $3.74 | $0.63 | 20.26% | 2.3K | $26M | $2.40$12.85 |
| TENX | Tenax Therapeutics | $13.25 | $2.23 | 20.24% | 27.4K | $69M | $4.63$18.38 |
| VYGR | Voyager Therapeutics | $4.92 | $0.81 | 19.71% | 121.4K | $229M | $2.65$5.55 |
| CLRB | Cellectar Biosciences | $3.28 | $0.53 | 19.27% | 126.5K | $12M | $2.45$20.59 |
| FIGR | Figure Technology Solutions | $38.83 | $6.19 | 18.96% | 1.1M | $7.0B | $25.00$78.00 |
| FGI | Fgi Industries | $4.05 | $0.64 | 18.92% | 18.1K | $6.5M | $2.28$12.62 |
| AXTI | AXT | $45.72 | $7.16 | 18.57% | 504.9K | $2.1B | $1.13$47.03 |
| UECG | Themes ETF Trust - Leverage Shares 2x Long Uec Daily ETF | $10.74 | $1.66 | 18.29% | 37.9K | - | $7.57$15.46 |
| QTTB | Q32 Bio | $5.99 | $0.89 | 17.45% | 363.5K | $66M | $1.35$6.37 |
| LFS | Leifras | $2.66 | $0.39 | 17.07% | 184.4K | $59M | $1.58$12.49 |
| SEV | Aptera Motors | $3.67 | $0.51 | 16.14% | 805.3K | $103M | $1.29$40.85 |
| APPX | Investment Managers Series Trust II - Tradr 2x Long App Daily ETF | $40.50 | -$7.65 | -15.89% | 790.4K | - | $20.21$157.62 |
| HSPTU | Horizon Space Acquisition II Corp. | $7.24 | -$4.37 | -37.64% | 34 | $66M | $7.24$13.50 |
Related Articles
Featured Article
1 Small-Cap Stock I'd Buy Before GLBE in 2026
Marc Guberti|Jan 8, 2026
Global-E Online is a small company trying to carve out a niche in the competitive e-commerce space, while AXT is a small semiconductor player that already has a lead in an emerging opportunity.
2 Biotech Stocks That Could Make You Richer
James Halley|Jul 14, 2023
These biotech companies are seeing a spike in revenue growth.
3 Growth Stocks You Can Buy Right Now With Less Than $100
Rick Munarriz|Nov 23, 2022
You don't need a lot money to buy into these fallen -- but not broken -- growth stocks. One has plummeted 97% this year.
Pfizer and Novartis Are Betting On This Under-the-Radar Biotech. Should You?
Keith Speights|Mar 19, 2022
Voyager Therapeutics has promising technology. But the stock is very risky.
Why Allbirds Stock Should Be on Your Watchlist
Trevor Jennewine|Nov 24, 2021
This newly public company makes high-tech shoes.
Parkinson's Disease Patients Get Long-Term Benefits From Experimental Gene Therapy
Cory Renauer|Sep 11, 2020
Three years after treatment with NBIb-1817, Parkinson's disease patients still are still showing improvements.
Is It Too Late to Jump In on Zentalis?
James Halley|Jun 3, 2020
The company's share price has nearly tripled since its IPO less than two months ago. Is it too late to get in on the fun?
Is Now a Good Time To Buy Neurocrine Biosciences?
James Halley|May 14, 2020
The biopharmaceutical company has seen shares rise 44.5% in less than two months.
3 Small-Cap Biotech Stocks That Surged Last Week
Cory Renauer|May 11, 2020
Here's what's behind their impressive market performances.
These 3 Biotechs Had Successful IPOs During the Coronavirus Crisis. Are They Buys?
David Haen|Apr 23, 2020
These companies just raised significant cash to advance promising drug pipelines.
